Could Fructose Help Ovarian Cancer Spread? New Study Uncovers Surprising Mechanism

A common dietary sugar has emerged as an unexpected factor in research into how ovarian cancer spreads after chemotherapy.

Scientists at The Wistar Institute found that ovarian cancer cells that survive chemotherapy can release fructose, which appears to act as a signal that makes neighbouring cancer cells more capable of spreading.

The research, published in Nature Aging, was conducted using laboratory and animal models. It does not establish that eating fructose causes ovarian cancer to spread in people, and the researchers say further studies are needed before the findings can influence patient care.

The research focused on cancer cells that survive treatment

Chemotherapy can kill large numbers of cancer cells, but some cells may survive treatment and enter a state known as cellular senescence.

These surviving cells may stop dividing while remaining biologically active. Researchers wanted to understand whether substances released by those cells could influence other cancer cells in their surroundings.

The team found that material released by chemotherapy-treated cells increased cancer-cell dissemination in preclinical experiments. Further analysis identified fructose as one of the key components involved in that process.

Aidan Cole, the study’s first author, said the findings point to a previously unrecognised role for nutrients as signalling molecules within the tumour environment.

Fructose appeared to change how neighbouring cells behave

The researchers found that fructose released by chemotherapy-surviving cells was taken up by neighbouring ovarian cancer cells.

Once inside those cells, the sugar was linked to metabolic changes that made it easier for the cells to detach from one another.

The experiments also indicated that high levels of dietary fructose could increase ovarian cancer dissemination in mice, even without chemotherapy. However, this result comes from an animal model and cannot be directly translated into the same effect in people.

Cholesterol emerged as an important part of the mechanism

The study also identified a connection between fructose and cholesterol production inside cancer cells.

Using several experimental approaches, including a CRISPR-based screen, researchers found that fructose affected a metabolic pathway involved in maintaining cholesterol in the cell membrane.

Cholesterol contributes to the structure and adhesion of cells. When cholesterol levels in the relevant cell membranes fell, cancer cells were more able to detach from surrounding cells, a process that can contribute to metastatic spread.

The researchers described this as a metabolic chain linking chemotherapy-induced changes to fructose signalling, reduced membrane cholesterol and increased cancer-cell detachment.

The findings also raise questions about statins

The cholesterol connection prompted the researchers to investigate statins, medicines commonly prescribed to lower cholesterol.

Their experiments suggested that statins could also reduce cholesterol production and affect the adhesion of cancer cells. That finding has raised questions about how cholesterol-lowering medication might interact with the biological processes observed in the study.

However, the researchers explicitly caution that these findings are not a reason for patients to stop taking statins.

Katherine Aird, the study’s senior author, said the potential interaction needs to be investigated further, particularly because ovarian cancer frequently affects postmenopausal women, many of whom may already use cholesterol-lowering medication.

Researchers stress that the study does not prove a dietary cause

One of the most important limitations is that the research has not been tested as a clinical intervention in humans.

The scientists have not established that reducing fructose intake slows ovarian cancer progression in patients. Equally, the study does not show that eating ordinary amounts of fructose causes cancer to spread.

The strongest experimental evidence came from preclinical models, including studies involving high-fructose diets in mice. The researchers say the possible implications for human cancer treatment and nutrition require additional investigation.

The research could change questions about chemotherapy and recurrence

The findings add another layer to scientists’ understanding of what can happen after chemotherapy.

Rather than viewing treatment-surviving cancer cells only as dormant remnants, the research suggests that some of these cells may continue influencing their surroundings by releasing biologically active substances.

For ovarian cancer, this could be significant because recurrence and metastatic spread remain major challenges. The Wistar team says the mechanism identified in its research could help explain how chemotherapy-induced changes in the tumour environment contribute to dissemination.

More cancers will now be investigated

The researchers are also interested in whether similar mechanisms occur in other forms of cancer.

Their current findings concern high-grade serous ovarian cancer, and it remains unclear whether the same fructose-driven process operates in cancers such as pancreatic, colorectal or liver cancer.

Further studies will be needed to determine whether the mechanism is relevant across different tumour types and, crucially, whether targeting it could eventually improve outcomes for patients.

What the findings mean for patients right now

For now, the study represents a new research lead rather than a change in cancer treatment or dietary guidance.

There is no evidence from this study that ovarian cancer patients should independently change prescribed medication or stop taking cholesterol-lowering drugs. The researchers themselves stress that their observations have not yet been confirmed in humans.

What the research does provide is a new explanation for how chemotherapy-surviving ovarian cancer cells may influence their surroundings — and a possible connection between fructose metabolism, cholesterol production and the ability of cancer cells to spread.